Introduction: The life experience of patients with advanced cancer and limited life expectancy is unique and profoundly complex, often leading to moral discrepancies among the various individuals involved in decision making. There are no data in the literature on the prevalence of ethical issues in the end-of-life care of patients with advanced cancer. Objectives: The primary objective of this study is to identify the overall and specific prevalence of ethical issues in the end-of-life care process for patients with advanced cancer. Method: We performed a secondary analysis using pooled data from the prospective development and validation cohorts of the PALCOM scale, focusing on the complexity of palliative care needs. This was performed to determine the overall and specific prevalence of ethical issues, describe their evolution over a 6-month follow-up period, and analyze their association with the level of palliative care complexity. Results: A total of 607 patients with advanced cancer and a life expectancy of 6 months or less were included. The consistency in clinical data and the frequencies of the PALCOM scale domains between the development and validation cohorts, conducted in various settings and times, confirmed the reliability of the pooled data sample. Systematic application of the PALCOM scale identified 126 patients (20.7%) who experienced at least one ethical issue. A total of 204 ethical issues (1.6 per patient) were recorded, related to the following: the proportionality of healthcare intervention (15.6%); information (13.0%); research (2.9%); the desire to hasten death (1.8%); and palliative sedation (0.15%). The monthly probability of presenting an ethical issue was significantly higher at the baseline visit (24.0%) compared to the rest of the 6-month follow-up period (14–17%) (p < 0.001). The prevalence of ethical issues was notably higher in patients with greater palliative care complexity as measured by the PALCOM scale: 4.5% in low complexity, 19.5% in medium complexity, and 30.8% in high complexity (p < 0.001). Conclusions: The prevalence of ethical issues in patients with advanced cancer is high. Most of these issues are directly or indirectly related to the preservation of patient autonomy in the decision-making process. The presence of ethical issues is significantly associated with the greater complexity of palliative care needs. In this context, it is crucial for healthcare professionals to strengthen both communication skills and basic competencies to effectively identify, assess, and manage these ethical issues.

Introduction: The increase in the inclusion of elderly people in hemodialysis programs is connected to a rise in the prevalence of their frailty, considered as well as a prediction of disability and often associated with adverse health events. Given its reversible nature, screening is essential to improve clinical practice. Objective: To assess the frailty index and the patient functional status in our hemodialysis unit, as well as analyze the differences between diabetics and non-diabetics. Material and Method: Observational cross-sectional study. Frailty was measured using the Fried phenotype and functional assessment using the Barthel, Lawton, Downton, and Short Physical Performance Battery scales. Comorbidity and fall risk were evaluated with the Charlson and Downton scales, respectively. Diabetic and non-diabetic groups were compared, as well as the relationship between frailty and age, dependency, comorbidity, and fall hazard was analyzed. Results: A hundred and twenty-eight patients were included in the study. 45% had diabetes. Diabetic patients had a higher average age than non-diabetics (74.2±11 vs 67.8±15 years) and higher comorbidity (Charlson 8.2±2.2 vs 5.8±2.4). Twenty-five percent of the patients had frailty, observing a trend that suggests higher frailty, worse functional capacity, and a higher degree of dependency in diabetic patients, although not significantly. Conclusions: A quarter of the sampled analyzed presents frailty, with a more pronounced tendency to suffer from it in the case of diabetic patients, which could be related to older age, higher comorbidity, and less functional capacity than non-diabetic people.

Introduction: The life experience of patients with advanced cancer and limited life expectancy is unique and profoundly complex, often leading to moral discrepancies among the various individuals involved in decision-making. There is no data in the literature on the prevalence of ethical issues in the end-of-life care of patients with ad-vanced cancer. Objectives: The primary objective of this study is to identify the overall and specific prevalence of ethical issues in the end-of-life care process for patients with advanced cancer. Method: We conducted a secondary analysis of pooled data from the prospective development and validation cohorts of the PALCOM scale for the complexity of palliative care needs. This was done to determine the overall and specific prevalence of ethical issues, describe their evolution over a 6-month follow-up period, and their association with the level of palliative care complexity. Results: A total of 607 patients with advanced cancer and a life expectancy of ≤ 6 months were included. The absence of significant differences in clinical data and the frequencies of the PALCOM scale domains between the development and validation cohorts, conducted in different settings and times, confirmed the reliability of the pooled data sample. Systematic application of the PALCOM scale identified 126 patients (20.7%) who experienced at least one ethical issue. A total of 204 ethical issues (1.6 per patient) were recorded, related to: proportionality of healthcare intervention (15.6%); information (13.0%); research (2.9%); desire to hasten death (1.8%); palliative sedation (0.15%). The monthly probability of presenting an ethical issue was significantly higher at the baseline visit (24.0%) compared to the rest of the 6-month follow-up period (14-17%) (p< 0.001) The prevalence of ethical issues was significantly higher in patients with greater palliative care complexity according to the PALCOM scale: 4.5% in low complexity; 19.5% in medium complexity; 30.8% in high complexity (p< 0.001). Conclusions: The prevalence of ethical issues in patients with advanced cancer is high. Most of these issues are directly or indirectly related to the preservation of patient autonomy in the decision-making process. The presence of ethical issues is significantly associated with greater complexity of palliative care needs. In this context, it is crucial for healthcare professionals to strengthen both communication skills and basic competencies to effectively identify, assess, and manage these ethical issues.

Introducción: El incremento en la inclusión de personas de edad avanzada a los programas de hemodiálisis se relaciona con un aumento de la prevalencia de fragilidad, considerada predictora de discapacidad y asociada a eventos adversos de salud. Dado su carácter reversible, es importante hacer un cribaje para mejorar la práctica clínica. Objetivo: Evaluar el grado de fragilidad y estado funcional del paciente en nuestra unidad de hemodiálisis y analizar las diferencias entre diabéticos y no diabéticos. Material y Método: Estudio observacional de corte transversal. La fragilidad se midió utilizando el fenotipo de Fried y la valoración funcional mediante las escalas Barthel, Lawton, Downton y la Short Physical Performance Battery. Se evaluó comorbilidad y riesgo de caídas con las escalas Charlson y Downton respectivamente. Se comparó entre grupos de diabéticos y no diabéticos y se analizó la relación entre la fragilidad y la edad, dependencia, comorbilidad y riesgo de caídas. Resultados: Se incluyeron 128 pacientes. El 45% tenían Diabetes. Los pacientes con diabetes tenían una edad media mayor que los no diabéticos (74,2±11 vs 67,8±15 años) y mayor comorbilidad (Charlson 8,2±2,2 vs 5,8±2,4). El 25% de los pacientes presentaron fragilidad, observando una tendencia que sugirió mayor fragilidad, peor capacidad funcional y mayor grado de dependencia en los pacientes diabéticos, aunque de forma no significativa. Conclusiones: Una cuarta parte de la población estudiada presenta fragilidad, con una tendencia más acusada a padecerla los pacientes diabéticos, que podría estar relacionada con mayor edad, mayor comorbilidad y menor capacidad funcional que los no diabéticos.